Medical Devices US

US Infection Prevention Products Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

US Infection Prevention Products Market Industry Trends and Forecast to 2034: Segmented by (Product, Setting, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

US · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $12.99 Bn Placeholder estimate
Estimate 2025 $13.43 Bn 40.6% of the global market
Projected 2034 $18.15 Bn 35.1% Adds $4.72 Bn over 9 forecast years
CAGR 2025–2034 3.4% Faster than 7% of 173 Medical Devices markets here
Key players 5 Companies profiled
  • US is 40.61% of the global market.
  • In North America, the largest is US (this report) at $13.43 Bn.
  • Fastest growing: Canada at 5.3% a year.
  • US ranks 1st of 2 by size in North America.

Market size projection

US

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$4.72 Bn total, 2026–2034

Year-by-year market size, 2024–2034
Infection Prevention Products Market market size by year, US
YearMarket sizeChange that yearSince 2025
2024 (estimate) $12.99 Bn — —
2025 (base) $13.43 Bn +$441.6 Mn —
2026 (forecast) $13.89 Bn +$456.7 Mn +3.4%
2027 (forecast) $14.36 Bn +$472.2 Mn +6.9%
2028 (forecast) $14.85 Bn +$488.2 Mn +10.6%
2029 (forecast) $15.35 Bn +$504.8 Mn +14.3%
2030 (forecast) $15.87 Bn +$522.0 Mn +18.2%
2031 (forecast) $16.41 Bn +$539.7 Mn +22.2%
2032 (forecast) $16.97 Bn +$558.1 Mn +26.4%
2033 (forecast) $17.55 Bn +$577.1 Mn +30.7%
2034 (forecast) $18.15 Bn +$596.7 Mn +35.1%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

US Infection Prevention Products Market Analysis at a glance
Market size, 2025$13.43 Bn placeholder estimate
Forecast, 2034$18.15 Bn placeholder estimate
Growth (CAGR), 2025–20343.4% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
Also calledInfection Control Products
SegmentsProduct, setting and end user (see all)
Key playersSTERIS, Ecolab, 3M Company, Getinge, Cantel (STERIS) (see all)
Regulator in the USFDASource: US Food and Drug Administration. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The US Infection Prevention Products Market Analysis Executive Summary

Infection prevention products stop germs spreading in hospitals and clinics, including disinfectants, sterilisation and protective equipment.

Key segments of the infection Prevention Products market include product (Disinfectants, Sterilization Equipment and Personal Protective Equipment) and setting (Hospitals, Clinics and Labs).

Bar chart: US Infection Prevention Products market size, 2024–2034, placeholder estimates. $12.99 Bn in 2024, $13.43 Bn in 2025 and $18.15 Bn in 2034, 3.4% CAGR.
US Infection Prevention Products market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

US Infection Prevention Products Market Dynamics

Market Growth Drivers

Rising antimicrobial resistance, outbreaks of new and returning diseases, climate change spreading infections and strong global funding for prevention are driving the infection Prevention Products market.

Opportunity

New vaccines, rapid tests and public-private funding for neglected diseases give the infection Prevention Products market room to grow, especially in Asia, Africa and Latin America.

Market Restraints

Low prices in poorer markets, weak returns for new antibiotics, vaccine hesitancy and cold-chain problems hold back the infection Prevention Products market.

Competitive Landscape for Infection Prevention Products Market in US

The infection Prevention Products market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Infection Prevention Products Market in US

Infection Prevention Products in the US: rules and payment

The FDA clears or approves medical devices by risk class, through 510(k) clearance, De Novo classification or premarket approval (PMA).⁠[1] Medicare covers people aged 65 and over and some younger people with disabilities, and Medicaid covers many people on low incomes; both are run with the Centers for Medicare & Medicaid Services (CMS).⁠[2]

[1] US Food and Drug Administration. Checked 14 Nov 2026.

[2] Centers for Medicare & Medicaid Services. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how infection Prevention Products products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in US.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Infection Prevention Products right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Infection Prevention Products in context

The US compared

  • Health spending per person: 13,473 US$ per person (2023). World: 1,317 US$ per person (2023).[1]
  • Doctors: 3.68 per 1,000 people (2022). World: 1.86 per 1,000 people (2022).[2]
  • People aged 65 and over: 18.4% of people (2025). World: 10.4% of people (2025).[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 18 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 18 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 18 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Infection Prevention Products market in the US?
Placeholder estimate: about $13.43 Bn in 2025, rising to about $18.15 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Infection Prevention Products market in the US growing?
Placeholder estimate: about 3.4% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Infection Prevention Products market report cover?
The report splits the market by product (Disinfectants, Sterilization Equipment, Personal Protective Equipment, Hand Hygiene), setting (Hospitals, Clinics, Labs) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Infection Prevention Products market?
Key players include STERIS, Ecolab, 3M Company, Getinge and Cantel (STERIS).
What is driving the Infection Prevention Products market?
Rising antimicrobial resistance, outbreaks of new and returning diseases, climate change spreading infections and strong global funding for prevention are driving the infection Prevention Products market.
Who regulates Infection Prevention Products in the US?
The FDA clears or approves medical devices by risk class, through 510(k) clearance, De Novo classification or premarket approval (PMA). Source: US Food and Drug Administration. Checked 14 Nov 2026.
How is healthcare paid for in the US?
Medicare covers people aged 65 and over and some younger people with disabilities, and Medicaid covers many people on low incomes; both are run with the Centers for Medicare & Medicaid Services (CMS). Source: Centers for Medicare & Medicaid Services. Checked 14 Nov 2026.
How much research is published on Infection Prevention Products?
PubMed lists 9,222 papers on Infection Prevention Products added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Medical Devices reports in US

See all

Related on infectious diseases and hospital

See the topic